GS
RCPI

George Soros’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

George Soros’s Portfolio RCPI Stock Details RCPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,512
Closed -$52K – 421
2014
Q2 		$52K Buy
+3,512
New +$60.9K ﹤0.01% 356

Other funds holding RCPI

GCM
Goldman Capital Management New York $103M AUM 21.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return

George Soros's RCPI Position: Q3 2014 in Review

George Soros sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q3 2014, closing a stake of 3,512 shares — an estimated $52K sold.

George Soros first reported a position in RCPI in Q2 2014 and held it in 1 quarter. The position peaked at $52K in Q2 2014. 67 funds tracked by Wall St. Rank hold RCPI as of Q3 2014.

  • George Soros reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • George Soros sold 3,512 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $52K.
  • George Soros first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 1 quarter.
  • George Soros's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $52K in Q2 2014.
  • 67 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Soros Fund Management's 13F filing for Q3 2014, filed 14 Nov 2014.